BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

709 related articles for article (PubMed ID: 28929089)

  • 1. Two Novel
    Zhao X; Dai Q; Jia R; Zhu D; Liu M; Wang M; Chen S; Sun K; Yang Q; Wu Y; Cheng A
    Front Cell Infect Microbiol; 2017; 7():391. PubMed ID: 28929089
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recombinant attenuated Salmonella Typhimurium with heterologous expression of the Salmonella Choleraesuis O-polysaccharide: high immunogenicity and protection.
    Zhao X; Dai Q; Zhu D; Liu M; Chen S; Sun K; Yang Q; Wu Y; Kong Q; Jia R
    Sci Rep; 2017 Jul; 7(1):7127. PubMed ID: 28754982
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulated delayed attenuation enhances the immunogenicity and protection provided by recombinant Salmonellaenterica serovar Typhimurium vaccines expressing serovar Choleraesuis O-polysaccharides.
    Zhao X; Liang S; Dai Q; Jia R; Zhu D; Liu M; Wang M; Chen S; Yang Q; Wu Y; Zhang S; Zhang L; Liu Y; Yu Y; Cheng A
    Vaccine; 2018 Aug; 36(33):5010-5019. PubMed ID: 30017143
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulated delayed synthesis of lipopolysaccharide and enterobacterial common antigen of Salmonella Typhimurium enhances immunogenicity and cross-protective efficacy against heterologous Salmonella challenge.
    Huang C; Liu Q; Luo Y; Li P; Liu Q; Kong Q
    Vaccine; 2016 Aug; 34(36):4285-92. PubMed ID: 27423383
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deletions in
    Fuche FJ; Jones JA; Ramachandran G; Higginson EE; Simon R; Tennant SM
    Hum Vaccin Immunother; 2019; 15(6):1427-1435. PubMed ID: 29927725
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protection against oral challenge three months after i.v. immunization of BALB/c mice with live Aro Salmonella typhimurium and Salmonella enteritidis vaccines is serotype (species)-dependent and only partially determined by the main LPS O antigen.
    Hormaeche CE; Mastroeni P; Harrison JA; Demarco de Hormaeche R; Svenson S; Stocker BA
    Vaccine; 1996 Mar; 14(4):251-9. PubMed ID: 8744548
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunological responses induced by asd and wzy/asd mutant strains of Salmonella enterica serovar Typhimurium in BALB/c mice.
    Piao HH; Tam VT; Na HS; Kim HJ; Ryu PY; Kim SY; Rhee JH; Choy HE; Kim SW; Hong Y
    J Microbiol; 2010 Aug; 48(4):486-95. PubMed ID: 20799091
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reversible synthesis of colanic acid and O-antigen polysaccharides in Salmonella Typhimurium enhances induction of cross-immune responses and provides protection against heterologous Salmonella challenge.
    Li P; Liu Q; Huang C; Zhao X; Roland KL; Kong Q
    Vaccine; 2017 May; 35(21):2862-2869. PubMed ID: 28412074
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protective Immunity Elicited by Oral Immunization of Mice with
    Erova TE; Kirtley ML; Fitts EC; Ponnusamy D; Baze WB; Andersson JA; Cong Y; Tiner BL; Sha J; Chopra AK
    Front Cell Infect Microbiol; 2016; 6():148. PubMed ID: 27891321
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulated delayed attenuation improves vaccine efficacy in preventing infection from avian pathogenic Escherichia coli O
    Han Y; Luo P; Chen Y; Xu J; Sun J; Guan C; Wang P; Chen M; Zhang X; Zhu Y; Zhu T; Zhai R; Cheng C; Song H
    Vet Microbiol; 2021 Mar; 254():109012. PubMed ID: 33611126
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A bivalent vaccine derived from attenuated Salmonella expressing O-antigen polysaccharide provides protection against avian pathogenic Escherichia coli O1 and O2 infection.
    Han Y; Liu Q; Willias S; Liang K; Li P; Cheng A; Kong Q
    Vaccine; 2018 Feb; 36(8):1038-1046. PubMed ID: 29358057
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulated Delayed
    Su H; Liu Q; Wang S; Curtiss R; Kong Q
    Theranostics; 2019; 9(12):3565-3579. PubMed ID: 31281498
    [No Abstract]   [Full Text] [Related]  

  • 13. Refined live attenuated Salmonella enterica serovar Typhimurium and Enteritidis vaccines mediate homologous and heterologous serogroup protection in mice.
    Tennant SM; Schmidlein P; Simon R; Pasetti MF; Galen JE; Levine MM
    Infect Immun; 2015 Dec; 83(12):4504-12. PubMed ID: 26351285
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulated delayed expression of rfaH in an attenuated Salmonella enterica serovar typhimurium vaccine enhances immunogenicity of outer membrane proteins and a heterologous antigen.
    Kong Q; Liu Q; Roland KL; Curtiss R
    Infect Immun; 2009 Dec; 77(12):5572-82. PubMed ID: 19805538
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An enterobacterial common antigen mutant of Salmonella enterica serovar Typhimurium as a vaccine candidate.
    Bridge DR; Whitmire JM; Gilbreath JJ; Metcalf ES; Merrell DS
    Int J Med Microbiol; 2015 Sep; 305(6):511-22. PubMed ID: 26070977
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heterologous Pseudomonas aeruginosa O-antigen delivery using a Salmonella enterica serovar Typhimurium wecA mutant strain.
    Bridge DR; Whitmire JM; Makobongo MO; Merrell DS
    Int J Med Microbiol; 2016 Nov; 306(7):529-540. PubMed ID: 27476047
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of deletion of genes involved in lipopolysaccharide core and O-antigen synthesis on virulence and immunogenicity of Salmonella enterica serovar typhimurium.
    Kong Q; Yang J; Liu Q; Alamuri P; Roland KL; Curtiss R
    Infect Immun; 2011 Oct; 79(10):4227-39. PubMed ID: 21768282
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of deletion of gene cluster involved in synthesis of Enterobacterial common antigen on virulence and immunogenicity of live attenuated Salmonella vaccine when delivering heterologous Streptococcus pneumoniae antigen PspA.
    Liu Q; Shen X; Bian X; Kong Q
    BMC Microbiol; 2020 Jun; 20(1):150. PubMed ID: 32513100
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhancement of immune responses by an attenuated Salmonella enterica serovar Typhimurium strain secreting an Escherichia coli heat-labile enterotoxin B subunit protein as an adjuvant for a live Salmonella vaccine candidate.
    Hur J; Lee JH
    Clin Vaccine Immunol; 2011 Feb; 18(2):203-9. PubMed ID: 21159921
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced immune response to a dual-promoter anti-caries DNA vaccine orally delivered by attenuated Salmonella typhimurium.
    Jiang H; Hu Y; Yang M; Liu H; Jiang G
    Immunobiology; 2017 May; 222(5):730-737. PubMed ID: 28187901
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.